Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 13, 2024

Primary Completion Date

April 29, 2025

Study Completion Date

April 29, 2025

Conditions

Sexually Transmitted Infection

Interventions

DRUG

Doxycycline

Doxycycline (DOX) will be given orally at 100mg doses. Participants will take the study medication for 7 consecutive days.

Trial Locations (1)

Hope Clinic, Atlanta

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

lead

Emory University

OTHER

NCT06545656 - Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens | Biotech Hunter | Biotech Hunter